Skip to main content
. 2022 Dec 30;14:194. doi: 10.1186/s13148-022-01397-2

Table 1.

Cohort summary statistics

Characteristics Mild (n = 119) Severe (n = 116) All (n = 235) Cohen’s d
Longitudinal ARMSS score Median (IQR) 1.21 (0.72, 1.86) 8.63 (7.86, 9.20) 2.86 (1.20, 8.62) 8.87
Range 0.17–3.01 6.52–9.92 0.17–9.92
Disease course at blood collection RRMS 118 (99.2%) 46 (39.6%) 163 (69.4%)
SPMS 0 (0.0%) 70 (60.4%) 71 (30.6%)
Disease course at most recent visit RRMS 117 (98.3%) 39 (33.6%) 157 (66.8%)
SPMS 1 (0.008%) 77 (66.4%) 78 (33.2%)
Sex Female 119 (100.0%) 116 (100.0%) 235 (100.0%)
Male 0 (0%) 0 (0%) 0 (0%)
Age at most recent visit Median (IQR) 53.57 (45.92, 62.14) 53.47 (45.34, 61.33) 52.41 (43.81, 59.31) 0.15
Range 29.00–76.35 28.80–76.35 28.80–76.21
Age at blood collection Median (IQR) 49.10 (40.75, 57.62) 48.40 (40.10, 56.50) 47.80 (39.85, 55.35) 0.11
Range 24.10–72.20 24.00–73.00 24.00–73.00
Symptom duration (years) Median (IQR) 15.90 (11.45, 20.98) 24.18 (19.65, 31.70) 19.92 (13.79, 26.49) 0.95
Range 5.85–38.11 11.91–47.13 5.85–47.13
ARR Median (IQR) 0.10 (0.00, 0.20) 0.17 (0.00, 0.38) 0.11 (0.00, 0.26) 0.39
Range 0.00–0.82 0.00–1.08 0.00–1.08
DMT at blood collection Yes 84 (70.5%) 68 (58.6%) 152 (64.7%)
No 35 (29.5%) 48 (41.4%) 83 (35.3%)
Follow-up in MSBase (years) Median (IQR) 11.76 (10.24, 14.24) 11.27 (9.78, 13.29) 11.13 (9.49, 12.59) 0.25
Range 5.15–21.96 5.15–32.16 5.26–32.16
Number of EDSS scores assessed Median (IQR) 15.00 (11.00, 21.25) 15.00 (11.00, 19.00) 14.00 (10.00, 18.00) 0.29
Range 3.00–47.00 3.00–47.00 3.00–34.00

ARMSS age-related multiple sclerosis severity score, IQR interquartile range, EDSS expanded disability status scale, ARR annualised relapse rate, DMT disease-modifying therapy

*MS course data missing for one patient